Healius Limited Overview
Pro stress-test →Healius Limited is Australia's leading pathology and diagnostic services provider, operating through multiple brands including Laverty Pathology, QML Pathology, and Dorevitch Pathology. The company serves patients across Australia through approximately 100 medical laboratories and 2,000+ patient collection centers, with expertise spanning pathology, genomics, diagnostic imaging, and specialty clinical services.
Strategic Profile
Pro stress-test →Healius operates an integrated healthcare diagnostics platform with strong market penetration across metropolitan, regional, and remote Australia. The company is positioned as an essential healthcare infrastructure provider, with pathology involved in 70% of medical decisions and all cancer diagnoses, providing recurring revenue and strategic importance to the healthcare ecosystem.
Competitive Landscape
Pro stress-test →Healius dominates the Australian pathology market with limited direct competitors given its comprehensive geographic footprint and integrated service offerings. Key market players include independent pathology providers and hospital-based laboratories, but Healius' scale and network create significant competitive advantages. The market is characterized by consolidation trends and increasing demand for specialty diagnostics and genomic testing.
Industry Context
Healius Limited operates in Healthcare Diagnostics & Pathology Services.
Key facts
Founded: 1994 · Headquarters: Sydney, Australia · Employees: 3,699 · Revenue: AUD 1.71B